HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eyelid dermatitis: contact allergy to 3-(dimethylamino)propylamine.

Abstract
We present the case of a 42-year-old woman with intractable eyelid dermatitis. Patch testing revealed sensitization to 3-(dimethylamino)propylamine (DMAPA). DMAPA is an important etiology of allergic contact dermatitis of the eyelids and face but is easily missed even with expanded-series patch testing. We also review the most common causative allergens in eyelid dermatitis cited in the literature over the past decade. DMAPA is a reagent used in the formation of cocamidopropyl betaine (CAPB), a common additive to liquid soaps, shampoos, and other cleansing products because of its utility as a surfactant. Beginning in the 1980s, reports of allergy to CAPB surfaced in the literature. Ultimately, a majority of patch testing studies have shown that clinical allergy to CAPB-containing products actually reflects allergy to contaminant DMAPA in most cases. Amidoamine, another intermediate in the formation of CAPB, may also be implicated through a proposed mechanism of conversion to DMAPA in the skin. When patch-testing for eyelid and facial dermatitis, it is crucial to test with DMAPA directly, not just with CAPB; unlike commercial-grade CAPB, the CAPB in patch test kits is ultrapure and does not contain contaminant DMAPA.
AuthorsEleanor Knopp, Kalman Watsky
JournalDermatitis : contact, atopic, occupational, drug (Dermatitis) 2008 Nov-Dec Vol. 19 Issue 6 Pg. 328-33 ISSN: 2162-5220 [Electronic] United States
PMID19134437 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Detergents
  • Diamines
  • cocoamidopropylbetaine
  • Betaine
  • 3-dimethylaminopropylamine
Topics
  • Adult
  • Betaine (adverse effects, analogs & derivatives)
  • Dermatitis, Allergic Contact (diagnosis, etiology)
  • Detergents (adverse effects)
  • Diamines (adverse effects)
  • Eyelids
  • Female
  • Humans
  • Patch Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: